Loading clinical trials...
Loading clinical trials...
Primary objectives of the study are: * To evaluate binocular visual acuity at the end of this study in patients included from the VGFTe-ROP-1920 study, for treatment of Retinopathy of Prematurity (RO...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Regeneron Pharmaceuticals
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT06315556 · Retinopathy of Prematurity, Preterm Infants
NCT05558059 · Retinopathy of Prematurity
NCT06067958 · Retinopathy of Prematurity, Dexmedetomidine
NCT06694103 · Retinopathy of Prematurity (ROP)
UCSD Shiley Eye Institute, Jacobs Retina Center
La Jolla, California
Loma Linda University Eye Institute
Loma Linda, California
University of California San Francisco - Ophthalmology
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions